ask="29.00"
ask_size="2000"
average_daily_volume="297095"
bid="3.35"
bid_size="4000"
book_value="0.56"
change="+0.14"
change_from_200_day_moving_average="1.38"
change_from_50_day_moving_average="0.61"
change_from_52_week_high="-0.67"
change_From_52_week_low="1.97"
change_in_percent="+3.60%"
close="4.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.11"
high_52_weeks="4.70"
last_trade_date="3/8/2017"
last_trade_price="4.03"
last_trade_size="736"
last_trade_time="4:00pm"
low="3.89"
low_52_weeks="2.06"
market_capitalization="75.31M"
moving_average_200_day="2.65"
moving_average_50_day="3.42"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="3.89"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+52.27%"
percent_change_from_50_day_moving_average="+17.67%"
percent_change_from_52_week_high="-14.26%"
percent_change_from_52_week_low="+95.62%"
previous_close="3.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.91"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="5.44"
stock_exchange="NCM"
symbol="BCLI"
volume="84227"
weeks_range_52="2.06 - 4.70"
